BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lopez-Cantu DO, Wang X, Carrasco-Magallanes H, Afewerki S, Zhang X, Bonventre JV, Ruiz-Esparza GU. From Bench to the Clinic: The Path to Translation of Nanotechnology-Enabled mRNA SARS-CoV-2 Vaccines. Nanomicro Lett 2022;14:41. [PMID: 34981278 DOI: 10.1007/s40820-021-00771-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Afewerki S, Stocco TD, Rosa da Silva AD, Aguiar Furtado AS, Fernandes de Sousa G, Ruiz-Esparza GU, Webster TJ, Marciano FR, Strømme M, Zhang YS, Lobo AO. In vitro high-content tissue models to address precision medicine challenges. Mol Aspects Med 2022;91:101108. [PMID: 35987701 DOI: 10.1016/j.mam.2022.101108] [Reference Citation Analysis]
2 Zaslavsky J, Bannigan P, Allen C. Re-envisioning the design of nanomedicines: harnessing automation and artificial intelligence. Expert Opin Drug Deliv 2023;:1-17. [PMID: 36644850 DOI: 10.1080/17425247.2023.2167978] [Reference Citation Analysis]
3 Arumugam GS, Damodharan K, Doble M, Thennarasu S. Significant perspectives on various viral infections targeted antiviral drugs and vaccines including COVID-19 pandemicity. Mol Biomed 2022;3:21. [DOI: 10.1186/s43556-022-00078-z] [Reference Citation Analysis]
4 Mohan B, Kumar S, Kumar V, Jiao T, Sharma HK, Chen Q. Electrochemiluminescence metal-organic frameworks biosensing materials for detecting cancer biomarkers. TrAC Trends in Analytical Chemistry 2022;157:116735. [DOI: 10.1016/j.trac.2022.116735] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Hsieh M, Yamaguchi Y. Immune Response in Regard to Hypersensitivity Reactions after COVID-19 Vaccination. Biomedicines 2022;10:1641. [DOI: 10.3390/biomedicines10071641] [Reference Citation Analysis]
6 Sanyaolu A, Okorie C, Marinkovic A, Prakash S, Williams M, Haider N, Mangat J, Hosein Z, Balendra V, Abbasi AF, Desai P, Jain I, Utulor S, Abioye A. Current advancements and future prospects of COVID-19 vaccines and therapeutics: a narrative review. Therapeutic Advances in Vaccines and Immunotherapy 2022;10:251513552210975. [DOI: 10.1177/25151355221097559] [Reference Citation Analysis]
7 Mahmud N, Anik MI, Hossain MK, Khan MI, Uddin S, Ashrafuzzaman M, Rahaman MM. Advances in Nanomaterial-Based Platforms to Combat COVID-19: Diagnostics, Preventions, Therapeutics, and Vaccine Developments. ACS Appl Bio Mater 2022. [PMID: 35583460 DOI: 10.1021/acsabm.2c00123] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
8 Chennamchetty VK, Kandi SC, Rao MR. Development of novel vaccines using nanomaterials against COVID-19. Nanotechnological Applications in Virology 2022. [DOI: 10.1016/b978-0-323-99596-2.00012-1] [Reference Citation Analysis]
9 Mollé LM, Smyth CH, Yuen D, Johnston APR. Nanoparticles for vaccine and gene therapy: Overcoming the barriers to nucleic acid delivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2022;14:e1809. [PMID: 36416028 DOI: 10.1002/wnan.1809] [Reference Citation Analysis]